Suggestions
Zoe Heineman
Solving diabetes every day.
Zoe Heineman is a highly experienced executive with a background in leading 11 global and US launches across various medical devices, software, pharmaceuticals, and diagnostics.
Her expertise lies in FDA regulatory strategy, clinical development, and coding and reimbursement for new healthcare products, along with extensive experience in US federal and state patient advocacy for over 30 years.
Zoe holds a Bachelor of Science from Georgetown University, a Master of Science in Life Sciences from The Johns Hopkins University, and an MBA in Pharmaceutical Marketing and Management from Rutgers Business School.
She has also studied Russian language and literature at Leningrad State University and the University of Virginia.
Zoe has held various senior roles, including Senior Vice President in North America at Diabeloop, Head Of US Commercial Operations at Thrombogenics, and President at Heineman Global Advisors, among others.
Highlights
Moving forward Paul Hudson and team! Congratulations on this decision which is greatly appreciated by the worldwide diabetes community. #Lantus is a helpful backup therapy for many pumpers when an infusion set fails, especially during the night when the need for sleep outweighs the need for a site change until morning. Sanofi
Hi everyone - Asking you to repost this, as I am actively conducting a search for a new opportunity with a US-based, for-profit medical technology company, in a long-term commercial role that will empower and improve the health of Americans who live with metabolic conditions, such as diabetes, pre-diabetes, menopause, gestational diabetes, hypoglycemia, congenital hyperinsulinism and obesity.
About me:
💼 Seeking a leadership role in healthcare, especially CGM, Software as a Service, Software as a Medical Device, or Drug Delivery and Diagnostic Connected Systems. My greatest value to an organization is my ability to drive growth in market adoption of blue-tooth connected technology supplemented by software, data platforms, machine learning and/or AI for people living with or caring for all types of diabetes, in outpatient or inpatient settings. I have broad and deep experience in clinical trial strategy, US healthcare policy, US reimbursement and FDA-CDRH submissions for devices receiving clearance with diabetes indications, such as infusion pumps, mobile apps and glucagon delivery devices.
🌎 Interested in a full-time role with a US-based, for-profit company.
⭐ Previously at Tidepool Project, Roche Diabetes Care, Diabeloop SA, Hygieia and Oxurion NV. I have several years of experience in management consulting to publicly-traded pharma companies, and advising analysts, private HNW investors, Family Offices, VC funds and healthcare investment banks.
If you are open to a discussion, feel free to send me a message or comment here. #OpenToWork
